Asymmetric and Symmetric Dimethylarginine as Risk Markers for Total Mortality and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Prospective Studies.

PLoS One · 2016 · PMC5094762 · PMID 27812151

Europe PMC DOI

hedged sentences

0.0680

closest p · 1.4× alpha

0.0720

boldest claim

The sentences

reached borderline significancep = 0.068so close (0.05 < p ≤ 0.1)

The association in patients with diabetes mellitus reached borderline significance [summary RR: 1.49; 95% CI, 0.99–2.25, p = 0.068; based on 4 studies].

also in 370 other papers

borderline significantp<0.072so close (0.05 < p ≤ 0.1)

In the dose-response meta-analysis, the risk of CVD increased by 3% per 0.1 μmol/L increment of SDMA [borderline significant: summary RR (95% CI): 1.03 (1.00–1.06), p<0.072; based on 9 studies].

also in 11,409 other papers

failed to reach statistical significanceno p-value reported

In patients with renal failure, the association failed to reach statistical significance.

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.